Skip to main content
Figure 2 | Experimental Hematology & Oncology

Figure 2

From: Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release

Figure 2

Effect of rivaroxaban and fondaparinux on the cells triggering the plasma recalcification clotting time. Non-activated or activated monocytes (A and B) and HP-1 cells (C and D) were used in the experiments. The cells were mixed with defibrinated plasma for 30 min and washed. Then CaCl2 and the cells were mixed with normal plasma and clotting time was recorded. The test was done in 5 independent experiments. E: Human thromboplastin was used to establish a linear curve in the same conditions without cells. *p < 0.05.

Back to article page